4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000041
CEO bought 275,000 shares at an average $0.02 ($4,437)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
23 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-28 | Purchase : show line 1 in the form | +10,000 | $0.02 | $160 | 24,439,097 | D |
| 2019-06-28 | Purchase : show line 2 in the form | +6,012 | $0.02 | $95 | 24,445,109 | D |
| 2019-06-28 | Purchase : show line 3 in the form | +43,988 | $0.02 | $704 | 24,488,097 | D |
| 2019-06-28 | Purchase : show line 4 in the form | +5,000 | $0.02 | $78 | 24,493,097 | D |
| 2019-06-28 | Purchase : show line 5 in the form | +25,000 | $0.02 | $395 | 24,518,097 | D |
| 2019-06-28 | Purchase : show line 6 in the form | +5,000 | $0.02 | $78 | 24,523,097 | D |
| 2019-06-28 | Purchase : show line 7 in the form | +25,000 | $0.02 | $398 | 24,548,097 | D |
| 2019-07-01 | Purchase : show line 8 in the form | +5,000 | $0.02 | $78 | 24,553,097 | D |
| Open-market purchases · 275,000 sh · avg $0.02 · $4,437 | ||||||
Loading xslF345X03/primary_doc.xml…